Literature DB >> 16758485

Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis.

Nina Browner1, Shaheda N Azher, Joseph Jankovic.   

Abstract

Patients with Rasmussen encephalitis (RE) may develop a variety of involuntary movements. We report a 26-year-old woman who presented with a 3-year history of progressive, continuous myoclonus of the left side of the face and left arm as well as left spastic hemiparesis. Magnetic resonance imaging of the brain showed right hemisphere and basal ganglia atrophy, and 24-hour electroencephalogram demonstrated diffuse slowing with random sharp waves in both hemispheres. An 18-fluoro-deoxy-glucose positron emission tomography scan indicated hypometabolism of the right cerebral hemisphere, including basal ganglia and thalamus. We successfully treated her myoclonus with injections of botulinum toxin A into the left zygomaticus muscle. (c) 2006 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16758485     DOI: 10.1002/mds.20991

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  5 in total

Review 1.  Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

Authors:  Sophia Varadkar; Christian G Bien; Carol A Kruse; Frances E Jensen; Jan Bauer; Carlos A Pardo; Angela Vincent; Gary W Mathern; J Helen Cross
Journal:  Lancet Neurol       Date:  2014-02       Impact factor: 44.182

Review 2.  Eponym : Rasmussen syndrome.

Authors:  Mario Mastrangelo; Rosanna Mariani; Alessandra Menichella
Journal:  Eur J Pediatr       Date:  2010-02-23       Impact factor: 3.183

3.  Hemichorea in Rasmussen's Encephalitis-A Rare Case.

Authors:  Abu Tahir Shaikh; Animesh Das; Ajay Garg; Divya M Radhakrishnan; Awadh Kishor Pandit; Ayush Agarwal; Achal Kumar Srivastava
Journal:  Mov Disord Clin Pract       Date:  2022-04-11

4.  Sustained Effect of Botulinum Neurotoxin in Myoclonus Owing to Epilepsia Partialis Continua.

Authors:  Janis Rebecca Bedarf; Milena Marek; Christian G Bien; Christian E Elger; Sebastian Paus
Journal:  Mov Disord Clin Pract       Date:  2015-07-15

Review 5.  Botulinum Toxin in Movement Disorders: An Update.

Authors:  Charenya Anandan; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2021-01-08       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.